Study Highlights Benefits of Risperdal Consta Over Zyprexa

Data from the first head-to-head trial of Johnson & Johnson’s injectable Risperdal Consta versus Zyprexa has highlighted the benefits of the former’s schizophrenia drug compared with Eli Lilly’s rival oral product.
Pharma Times